Concepedia

Daniel Panarotto

DP

8

Publications

555

Citations

8

H-Index

2000

Active since

Affiliations

Stanford University(Current)

Université de Sherbrooke

University of Groningen

University College London

University Medical Center Groningen

Daniel Panarotto is an author at Stanford University specializing in metabolic syndrome, medicine, and physiology.

Top concepts

Publications per year

2000–2023

8

Publications

8

Insulin resistance affects the regulation of lipoprotein lipase in the postprandial period and in an adipose tissue‐specific manner

Daniel Panarotto, Patrick Rémillard, L. Bouffard et al. · European Journal of Clinical Investigation · 2002 · 129 citations

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 118 citations · Full text

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 111 citations · Full text

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 92 citations · Full text

The use of psychoactive substances among medical students in southern Brazil

Márcio Manozzo Boniatti, Carlos Zúbaran, Daniel Panarotto et al. · Drug and Alcohol Review · 2007 · 30 citations

Rows per page

1–5 of 8